METTL14 and acute myeloid leukemia: It was found that MELLT3 and METTL14 play a cancer-promoting role in AML, promoting the translation of MYC, MYB, BCL2, SP1, and PTEN, thereby leading to significant gene mutations and causing great difficulties in treatment.